Inhibition of NF-κB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice

Journal of Clinical Investigation

Volumn 112, Issue 8, 2003, Pages 1176-1185

  Kanters, Edwin ^a   Pasparakis, Manolis ^b   Gijbels, Marion J J ^c   Vergouwe, Monique N ^c   Partouns Hendriks, Iris ^c   Fijneman, Remond J A ^a   Clausen, Björn E ^d   Förster, Irmgard ^e   Kockx, Mark M ^f   Rajewsky, Klaus ^g   Kraal, Georg ^a   Hofker, Marten H ^c   De Winther, Menno P J ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f MIDDELHEIM HOSPITAL   (Belgium)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DIFFERENTIATION ANTIGEN; HIGH DENSITY LIPOPROTEIN; I KAPPA B; I KAPPA B KINASE; I KAPPA B KINASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; CHUK PROTEIN, MOUSE; IKBKB PROTEIN, MOUSE; IKBKE PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL COUNT; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENDOCYTOSIS; GENE DELETION; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; SOUTHERN BLOTTING; TRANSCRIPTION REGULATION; ANIMAL; ARTERIOSCLEROSIS; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL DIFFERENTIATION; DRUG ANTAGONISM; MACROPHAGE; METABOLISM; PHAGOCYTOSIS; PHYSIOLOGY;

ANIMALS; ARTERIOSCLEROSIS; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; I-KAPPA B KINASE; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MICE, INBRED C57BL; NF-KAPPA B; PHAGOCYTOSIS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, LDL;

EID: 0346727295     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200318580     Document Type: Article

References (33)

1. Lusis, A.J. 2000. Atherosclerosis. Nature. 407:233-241.
2. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801-809.
3. Libby, P. 2002. Inflammation in atherosclerosis. Nature. 420:868-874.
4. Collins, T., and Cybulsky, M.I. 2001. NF-kappaB: pivotal mediator or innocent bystander in acherogenesis? J. Clin. Invest. 107:255-264.
5. Brand, K., et al. 1996. Activated transcription factor nuclear factor-kappa B is present in the athetosclerotic lesion. J. Clin. Invest. 97:1715-1722.
6. Karin, M., and Ben-Neriah, Y. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:621-663.
7. Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F., and Verma, I.M. 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science. 284:321-325.
8. Li, Z.W., et al. 1999. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189:1839-1845.
9. Pasparakis, M., et al. 2002. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature. 417:861-866.
10. Clausen, B.E., Burkhardt, C., Reith, W., Renkawitz, R., and Forster, I. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:265-277.
11. Ishibashi, S., et al. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:883-893.
12. de Winther, M.P., et al. 1999. Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice. Atherosclerosis. 144:315-321.
13. Gijbels, M.J., et al. 1999. Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study. Atherosclerosis. 143:15-25.
14. Kockx, M.M., Muhring, J., Knaapen, M.W., and de Meyer, G.R. 1998. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am. J. Pathol. 152:885-888.
15. Peiser, L., Gough, P.J., Kodama, T., and Gordon, S. 2000. Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect. Immun. 68:1953-1963.
16. Hume, D.A., and Gordon, S. 1983. Optimal conditions for proliferation of bone marrow-derived mouse macrophages in culture: the roles of CSF-1, serum, Ca2+, and adherence. J. Cell Physiol. 117:189-194.
17. Schmidt-Supprian, M., et al. 2000. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol. Cell. 5:981-992.
18. Hendriks, W.L., van der Boom, H., van Vark, L.C., and Havekes, L.M. 1996. Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages. Biochem. J. 314:563-568.
19. Steinbrecher, U.P., Witztum, J.L., Parthasarathy, S., and Steinberg, D. 1987. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 7:135-143.
20. Underhill, D.M., et al. 1999. The toll-like receptor 2 is recruited to macrophage phagosomes mad discriminates between pathogens. Nature. 401:811-815.
21. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S., and Baltimore, D. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 376:167-170.
22. Tanaka, M., et al. 1999. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity. 10:421-429.
23. van Vlijmen, B.J., et al. 1994. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J. Clin. Invest. 93:1403-1410.
24. Pasparakis, M., Schmidt-Supprian, M., and Rajewsky, K. 2002. IkappaB kinase signaling is essential for maintenance of mature B cells. J. Exp. Med. 196:743-752.
25. Zhou, X., and Hansson, G.K. 1999. Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand. J. Immunol. 50:25-30.
26. Edfeldt, K., Swedenborg, J., Hansson, G.K., and Yan, Z.Q. 2002. Expressien of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation. 105:1158-1161.
27. Elhage, R., et al. 2001. Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. Atherosclerosis. 156:315-320.
28. Schreyer, S.A., Vick, C.M., and LeBoeuf, R.C. 2002. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice. J. Biol. Chem. 277:12364-12368.
29. Schreyer, S.A., Peschon, J.J., and LeBoeuf, R.C. 1996. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J. Biol. Chem. 271:26174-26178.
30. Mallat, Z., et al. 1999. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85:e17-e24.
31. Lang, R., Rutschman, R.L., Greaves, D.R., and Murray, P.J. 2002. Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J. Immunol. 168:3402-3411.
32. Giambartolomei, G.H., Dennis, V.A., Lasater, B.L., Murthy, P.K., and Philipp, M.T. 2002. Autocrine and exocrine regulation of interleukin-10 production in THP-1 cells stimulated with Borrelia burgdorferi lipoproteins. Infect. Immun. 70:1881-1888.
33. Lawrence, T., Gilroy, D.W., Colville-Nash, P.R., and Willoughby, D.A. 2001. Possible new role for NF-kappaB in the resolution of inflammation. Nat. Med. 7:1291-1297.